New Therapeutic Modalities In Testing For Patients With Carcinoid Syndrome
Nurses’ Work Environment Needs Change To Protect Patients From Errors, IOM Says
High Radiation Dose Effective Ten Years After Treatment
New Risk Stratification Method For Prostate Cancer Described
Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan
Survival After Liver Transplant Called Excellent In Study
Tumor Size Predicts Survival In Early-Stage Lung Cancer
B-27 Finds Improved CR For Taxotere Prior To Surgery
Studies Link Age-Dependent Outcome To Immune Cells
Clinical Trials Approved By NCI
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Protecting the cure: Why the future of radiation oncology must be precision-guided
- Letai: Perceptions aside, money is flowing and the cancer research infrastructure is sturdy
NCI expects record-breaking spending on extramural research - Chernobyl: a 35 year follow up on long-term health effects
- Cancer AI Alliance announces first wave of pilot projects









